Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2022-02-02 00:00:00 ET · period of report 2022-02-01 · accession 0001708138-22-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-02-02 | 2022-02-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $607.14 | -100 | 22.6K | -0.4% | -$60.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-01 | S | D | 7 | $605.50 | 22,552 | D | — | — | (F4) Represents volume-weighted average price of sales of 7 shares of Company stock on February 1, 2022 at prices ranging from $605.19 to $605.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 2 | Common | Common Stock | 2022-02-01 | S | D | 20 | $606.74 | 22,532 | D | — | — | (F5) Represents volume-weighted average price of sales of 20 shares of Company stock on February 1, 2022 at prices ranging from $606.07 to $606.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 3 | Common | Common Stock | 2022-02-01 | S | D | 3 | $607.56 | 22,529 | D | — | — | (F6) Represents volume-weighted average price of sales of 3 shares of Company stock on February 1, 2022 at prices ranging from $607.46 to $607.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 4 | Common | Common Stock | 2022-02-01 | S | D | 1 | $608.74 | 22,528 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-01 | S | D | 36 | $609.50 | 22,492 | D | — | — | (F7) Represents volume-weighted average price of sales of 36 shares of Company stock on February 1, 2022 at prices ranging from $609.00 to $609.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 6 | Common | Common Stock | 2022-02-01 | S | D | 5 | $610.17 | 22,487 | D | — | — | (F8) Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2022 at prices ranging from $610.02 to $610.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 7 | Common | Common Stock | 2022-02-01 | S | D | 5 | $611.33 | 22,482 | D | — | — | (F9) Represents volume-weighted average price of sales of 5 shares of Company stock on February 1, 2022 at prices ranging from $611.06 to $611.60. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 8 | Common | Common Stock | 2022-02-01 | S | D | 1 | $604.26 | 22,559 | D | — | — | |
| 9 | Common | Common Stock | 2022-02-01 | S | D | 6 | $603.61 | 22,560 | D | — | — | (F3) Represents volume-weighted average price of sales of 6 shares of Company stock on February 1, 2022 at prices ranging from $603.06 to $603.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 10 | Common | Common Stock | 2022-02-01 | S | D | 13 | $602.35 | 22,566 | D | — | — | (F2) Represents volume-weighted average price of sales of 13 shares of Company stock on February 1, 2022 at prices ranging from $602.09 to $602.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2022 at each separate price. |
| 11 | Common | Common Stock | 2022-02-01 | S | D | 2 | $600.89 | 22,580 | D | — | — | |
| 12 | Common | Common Stock | 2022-02-01 | S | D | 1 | $601.79 | 22,579 | D | — | — |